LANDBLOOM RONALD P 4
4 · Orexigen Therapeutics, Inc. · Filed Aug 27, 2008
Insider Transaction Report
Form 4
LANDBLOOM RONALD P
VP, Medical and Regulatory
Transactions
- Exercise/Conversion
Common Stock
2008-08-25$2.00/sh+40,000$80,000→ 40,000 total - Sale
Common Stock
2008-08-25$11.28/sh−40,000$451,200→ 0 total - Exercise/Conversion
Common Stock (right to buy)
2008-08-25−40,000→ 200,000 totalExercise: $2.00Exp: 2016-09-28→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/18/2007.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.00 to $11.92 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]As of August 25, 2008 and prior to this transaction, 109,791 shares of common stock subject to the option were vested. Approximately 5,208 shares of common stock subject to the option vest on the 15th day of each month until September 15, 2010.
- [F4]Not applicable.